Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abhai, Inc. is a privately held pharmaceutical company headquartered in Piscataway, New Jersey, specializing in the development and manufacturing of generic prescription medications. The company operates a state-of-the-art, FDA-approved facility capable of producing various dosage forms, including oral solids, liquids, and topical products. Abhai focuses on providing cost-effective healthcare solutions by maintaining a robust internal portfolio of generic drugs and offering contract development and manufacturing (CDMO) services to external partners. Its product line spans multiple therapeutic areas, with a particular emphasis on metabolic disorders, neurology, and cardiovascular health. The company is committed to high-quality standards and regulatory excellence to ensure the safety and efficacy of its products for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Abhai.